G. Stankus

Differential effects of two fluorescent probes on macrophage migration as assessed by manual and automated methods.

E. Denholm, G. Stankus, 1995, Cytometry.

The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems

H. Sarau, R. Ames, J. Foley, 2006, British journal of pharmacology.

Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal Species

G. Stankus, L. Walton, A. Alousi, 1983, Journal of cardiovascular pharmacology.

Urotensin-II: a novel systemic hypertensive factor in the cat

D. Behm, D. Johns, C. Doe, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2

W. Bao, D. Behm, S. Nerurkar, 2008, Journal of Pharmacology and Experimental Therapeutics.